The 2020 American Diabetes Association Standards of Medical Care in Diabetes reflect significant advances in therapeutic strategies that have evolved over the past several years, including the earlier use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for appropriate patients with type 2 diabetes. In this series of short Sound Advice audio modules, an expert in diabetes discusses real-world issues in applying these new guidelines to patient care. Each module will provide 0.25 CE/CME credits.

Faculty

Davida F. Kruger, MSN, APN-BC, BC-ADM
Certified Nurse Practitioner
Division of Endocrinology, Diabetes, and Bone and Mineral Disorders
Henry Ford Health System
Detroit, Michigan

Download a Free GLP-1 RA Shared Decision-Making Tool